CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 22 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Oxytocin 10 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04105998
NCT04105998Phase 4Completed
CompareCT.gov

Effects of Intramuscular Oxytocin on Pupil Diameter and Heart Rate Variability

Wake Forest University Health Sciences·interventional·Posted Sep 26, 2019·Updated Nov 10, 2022

In Brief

A Phase 4 clinical trial evaluating Oxytocin and Placebo for Chronic Pain Due to Injury. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The goal of this study is to test the effects of oxytocin on heart rate variability and pupil diameter, both of which have subtle effects on the activity rate of the autonomic nervous system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain Due to Injury
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedSep 26, 2019
Enrollment StartOct 24, 2019
Primary CompletionNov 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 6.8 years ago

Interventions

Oxytocindrug

Oxytocin 10 IU

Placebodrug

Placebo